John Conley is a Board Member and Investor of Launchpad Venture Group in Boston. He is a Director for two healthcare startups and works with a variety of social enterprises. He has been the Chief Operating Officer of Entrepreneurship for All, a nonprofit that is accelerating economic and social impact through fostering entrepreneurship in mid-sized cities.
He was a co-founder of the RNA interference therapeutics company Alnylam Pharmaceuticals where he held the position of Vice President, Strategy and Finance and CFO through to its successful 2004 IPO. He was Vice President of Business Development at Transkaryotic Therapies through to its acquisition by Shire Pharmaceuticals. Over ten years at Biogen he served in several marketing, business development, sales and finance positions, including Country Manager - United Kingdom and Ireland, and Treasurer. He was a Manager at the strategy consulting firm Bain & Company.
Mr. Conley graduated with a BS in Economics from the University of Pennsylvania's Wharton School and an MBA from the Yale School of Management. He was a 2014 Fellow in the Advanced Leadership Initiative at Harvard University.
Can help with
Strategy, pitch decks, capital raising, business model, licensing and partnerships
